Moreover, heightened levels of lactic acid in the tumor microenvironment exert an immunosuppressive effect, activating the immune checkpoint PD-1 and instigating resistance against PD-L1/PD-1 therapy [9]. The gene discussed is CD274; the disease is neoplasm.